A más de 100 años, y aun no derrotada: ácido acetilsalicílico. Su historia y recomendaciones actuales

Acetyl-salicylic acid, one of the most widely used drugs in cardiovascular medicine, was synthesized in 1897 by the German pharmaceutical chemist Felix Hoffman.Its history is not exempted of difficulties and fortuitous events.What is remarkable is how a medicine created in the past to fulfill an anti-inflammatory effect, became one of the cornerstone drugs in the prevention and treatment of cardiovascular diseases in the last 50 years.In view of the latest evidence that has reduced its indication in primary cardiovascular prevention, and the debate between the benefit and risk of its use, we consider useful to provide update data to clinicians about its prescription according to each patient's profile.

Authors

Institutions

Publication Details

Journal
Revista chilena de cardiología
Published
2025-12-01
DOI
https://doi.org/10.4067/s0718-85602025000300225
Primary Topic
Medical research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A más de 100 años, y aun no derrotada: ácido acetilsalicílico. Su historia y recomendaciones actuales

Mónica Acevedo, Paola Varleta O, César Del Castillo G.
Revista chilena de cardiología
Medical research and treatments
article

A más de 100 años, y aun no derrotada: ácido acetilsalicílico. Su historia y recomendaciones actuales

Mónica Acevedo, Paola Varleta O, César Del Castillo G.
article en

Abstract

Acetyl-salicylic acid, one of the most widely used drugs in cardiovascular medicine, was synthesized in 1897 by the German pharmaceutical chemist Felix Hoffman.Its history is not exempted of difficulties and fortuitous events.What is remarkable is how a medicine created in the past to fulfill an anti-inflammatory effect, became one of the cornerstone drugs in the prevention and treatment of cardiovascular diseases in the last 50 years.In view of the latest evidence that has reduced its indication in primary cardiovascular prevention, and the debate between the benefit and risk of its use, we consider useful to provide update data to clinicians about its prescription according to each patient's profile.

Revista chilena de cardiologíaVol. 44(3)
Hospital Dipreca (CL), Universidad Diego Portales (CL)
Openalex Percentile: Top 21%
Medical research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.